Skip to main content
Top
Published in: European Radiology 12/2015

01-12-2015 | Chest

Lung cancer risk and cancer-specific mortality in subjects undergoing routine imaging test when stratified with and without identified lung nodule on imaging study

Authors: Noemi Gómez-Sáez, Ildefonso Hernández-Aguado, José Vilar, Isabel González-Alvarez, María Fermina Lorente, María Luisa Domingo, María Pastor Valero, Lucy Anne Parker, Blanca Lumbreras

Published in: European Radiology | Issue 12/2015

Login to get access

Abstract

Objectives

To assess the risk of lung cancer and specific mortality rate in patients with and without solitary pulmonary nodules (SPN) on chest radiograph and CT.

Methods

This prospective study included 16,078 patients ≥35 years old (893 of them had an SPN detected with either chest radiograph or CT) and 15,185 without SPN. Patients were followed up for 18 months or until being diagnosed with lung cancer. Risk and mortality lung cancer were calculated in both groups with Poisson regression.

Results

In patients with SPN, incidence of lung cancer was 8.3 % (95 % CI 6.0–11.2) on radiograph and 12.4 % (95 % CI 9.3–15.9) on CT. A chronic obstructive pulmonary disease in patients with radiographs (odds ratio 2.62; 95 % CI 1.03, 6.67) and smoking habit (odds ratio 20.63; 95 % CI 3.84, 110.77) in patients with CT were associated with a higher probability of lung cancer. Large nodule size and spiculated edge were associated with lung cancer on both CT and radiograph. Lung cancer-specific mortality was lower in patients with SPN than in those without SPN (1.73/1000 person-years, 95 % CI 1.08–2.88 vs. 2.15/1000 person-years, 95 % CI 1.25–3.96).

Conclusions

The risk of lung cancer for patients with SPN is higher in clinical populations than in screening studies. Moreover, patients with SPN showed lower mortality than those without SPN.

Key Points

Lung cancer risk is 8 % for SPN detected on routine radiographs.
Lung cancer risk is 12.4 % for SPN detected in routine chest CT.
Smoking, COPD, SPN diameter and edge were predictors of malignancy.
Lung cancer risk of SPN in routine practice seems higher than in screening.
Literature
1.
go back to reference Gould MK, Fletcher J, Iannettoni MD et al (2007) American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:108S–130SCrossRefPubMed Gould MK, Fletcher J, Iannettoni MD et al (2007) American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 132:108S–130SCrossRefPubMed
2.
go back to reference Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e93S–e120SPubMedCentralCrossRefPubMed Gould MK, Donington J, Lynch WR et al (2013) Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:e93S–e120SPubMedCentralCrossRefPubMed
3.
go back to reference Aberle DR, DeMello S, Berg CD, National Lung Screening Trial Research Team et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:920–931PubMedCentralCrossRefPubMed Aberle DR, DeMello S, Berg CD, National Lung Screening Trial Research Team et al (2013) Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 369:920–931PubMedCentralCrossRefPubMed
4.
go back to reference Heuvers ME, Wisnivesky J, Stricker BH, Aerts JG (2012) Generalizability of results from the National Lung Screening Trial. Eur J Epidemiol 27:669–672CrossRefPubMed Heuvers ME, Wisnivesky J, Stricker BH, Aerts JG (2012) Generalizability of results from the National Lung Screening Trial. Eur J Epidemiol 27:669–672CrossRefPubMed
5.
go back to reference Winkler Wille MM, van Riel SJ, Saghir Z et al (2015) Predictive accuracy of the PanCan lung cancer risk prediction model–external validation based on CT from the Danish Lung Cancer Screening Trial. Eur Radiol. doi:10.1007/s00330-015-3689-0 PubMed Winkler Wille MM, van Riel SJ, Saghir Z et al (2015) Predictive accuracy of the PanCan lung cancer risk prediction model–external validation based on CT from the Danish Lung Cancer Screening Trial. Eur Radiol. doi:10.​1007/​s00330-015-3689-0 PubMed
6.
7.
go back to reference Devaraj A (2015) Missed cancers in lung cancer screening - more than meets the eye. Eur Radiol 25:89–91CrossRefPubMed Devaraj A (2015) Missed cancers in lung cancer screening - more than meets the eye. Eur Radiol 25:89–91CrossRefPubMed
8.
go back to reference Gómez-Sáez N, González-Álvarez I, Vilar J et al (2014) Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study. Eur Radiol 24:2174–2182PubMedCentralCrossRefPubMed Gómez-Sáez N, González-Álvarez I, Vilar J et al (2014) Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study. Eur Radiol 24:2174–2182PubMedCentralCrossRefPubMed
9.
go back to reference Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRefPubMed Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J (2008) Fleischner Society: glossary of terms for thoracic imaging. Radiology 246:697–722CrossRefPubMed
10.
go back to reference Fritz A, Percy C, Jack A et al (eds) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva Fritz A, Percy C, Jack A et al (eds) (2000) International classification of diseases for oncology, 3rd edn. World Health Organization, Geneva
11.
go back to reference Li Y, Chen KZ, Wang J (2011) Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin Lung Cancer 12:313–319CrossRefPubMed Li Y, Chen KZ, Wang J (2011) Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin Lung Cancer 12:313–319CrossRefPubMed
12.
go back to reference Siegelman SS, Khouri NF, Leo FP et al (1986) Solitary pulmonary nodules: CT assessment. Radiology 160:307–312CrossRefPubMed Siegelman SS, Khouri NF, Leo FP et al (1986) Solitary pulmonary nodules: CT assessment. Radiology 160:307–312CrossRefPubMed
13.
go back to reference Lee HY, Choi YL, Lee KS et al (2014) Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 202:W224–W233CrossRefPubMed Lee HY, Choi YL, Lee KS et al (2014) Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management. AJR Am J Roentgenol 202:W224–W233CrossRefPubMed
Metadata
Title
Lung cancer risk and cancer-specific mortality in subjects undergoing routine imaging test when stratified with and without identified lung nodule on imaging study
Authors
Noemi Gómez-Sáez
Ildefonso Hernández-Aguado
José Vilar
Isabel González-Alvarez
María Fermina Lorente
María Luisa Domingo
María Pastor Valero
Lucy Anne Parker
Blanca Lumbreras
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 12/2015
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-015-3775-3

Other articles of this Issue 12/2015

European Radiology 12/2015 Go to the issue